More than 500,000 people who have been vaccinated against Covid-19 will be delayed for up to 12 weeks as the NHS reconsiders the release aimed at ending the death toll in the UK.
In a UK-wide policy change, the NHS will now prioritize providing as many people on the priority list as possible with the first dose of Oxford / Astra Zeneca vaccine. newly approved or the Pfizer / BioNTech injection, so that the maximum number of people protected from the disease is increased.
Recipients will still receive the two doses needed to provide full immunity, but now the second one will be delayed, in most cases coming 11 to 12 weeks after first.
Previously, those receiving the Pfizer injection had a second dose date three weeks later from their first dose. That gap was initially expected to be four weeks for the Oxford vaccine.
Sir Simon Stevens, chief executive of NHS England, unveiled the move in a letter to health service leaders in England on Wednesday, a day on which an additional 981 Covid deaths were announced.
It also revealed that the NHS hoped to vaccinate all 25 million people in its nine priority groups by the end of spring, the first time an NHS director or government minister has set a date for when vulnerable people will be able to have the vaccine.
Dr Julia Patterson, director of EveryDoctor, a network of local doctors, said: “This sudden change to the government’s plan will put a huge strain on NHS staff delivering vaccines, and will also be a cause for concern. for vulnerable people who received the first dose of the vaccine and are now unsure about when to get the second dose.
“The government should quickly recruit a large additional workforce to deliver the vaccines, for example by enlisting the army, and not just overburdening the military. NHS work. ”
The delayed move in second doses means that most of the hundreds of thousands of people in England who received their first injection, after using the Pfizer product that started in the UK on 8 December, wait until as long as March for a second.
Top medical officials of the four home countries have approved the policy change amid growing expectations that the daily death toll will exceed 1,000, given the explosion in diseases and hospitals in recent weeks.
There is also great concern that the NHS is recovering rapidly with the number of people who are now critically ill in hospital, particularly in the south of England. Buckinghamshire Essex continued on Wednesday to report a “major incident” in response to the Covid-19 emergency.
Explaining the rationale for the change, chief medical officers said in a statement, Stevens said in his letter: “By prioritizing the first doses of vaccine for as many people as possible on the list priority will protect the greatest number of people at risk overall. in the shortest possible time and will have the greatest impact on reducing mortality, serious disease and hospitals and in protecting the NHS and equal health services.
“Actively, this will mean that a second dose of both vaccines will be given near the end of the recommended 12-week dose schedule.”
In his letter Stevens makes it clear:
-
Anyone who is about to receive their second dose before another Monday can do so.
-
Recruitment dates for those with a second dose due after 4 January “should be rescheduled mainly for between three [weeks’](for the Pfizer / BioNTech vaccine) and four [weeks’] (for the Astra Zeneca vaccine) and 12 weeks, and most recipients will be retained in the last week of that 12-week period ”.
-
Those about to receive the first injection from New Year’s Eve onwards should not receive the second dose until up to 12 weeks later. “Most recipients will be retained in the last week of that 12-week period. “
In a move that will warmly welcome NHS staff, Stevens also confirmed that the forthcoming Oxford vaccine – which will go live on Monday – means that staff vaccination can begin immediately.
Hospital and GP leaders, and frontline staff, have become increasingly vocal in recent weeks over concerns that they could leave NHS staff without a home. vaccinated the risk of both themselves and patients appearing at a time when the coronavirus is still rampant.